| Identification | Back Directory | [Name]
9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | [CAS]
1256579-06-2 | [Synonyms]
9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
9-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile
5H-Benzo[b]carbazole-3-carbonitrile, 9-bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-
9-BROMO-8-HYDROXY-6,6-DIMETHYL-11-OXO -6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE _1256579-06-2 | [Molecular Formula]
C19H13BrN2O2 | [MDL Number]
MFCD28098314 | [MOL File]
1256579-06-2.mol | [Molecular Weight]
381.22 |
| Chemical Properties | Back Directory | [InChI]
InChI=1S/C19H13BrN2O2/c1-19(2)12-7-15(23)13(20)6-11(12)17(24)16-10-4-3-9(8-21)5-14(10)22-18(16)19/h3-7,22-23H,1-2H3 | [InChIKey]
FTLQDYMGJVZZLI-UHFFFAOYSA-N | [SMILES]
N1C2=C(C=CC(C#N)=C2)C2=C1C(C)(C)C1=CC(O)=C(Br)C=C1C2=O |
| Hazard Information | Back Directory | [Uses]
9-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile is an intermediate of Alectinib (C183360), a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. |
|
|